Mode
Text Size
Log in / Sign up

Ovarian diseases

Part of Adnexal Diseases

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Ovarian diseases

2 trials tracked for Ovarian diseases.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
  1. N/A Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment Completed
  2. N/A Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Adnexal Diseases

Related studies from across the Adnexal Diseases family.

Narrative review links lactylation modification to gynecological disease pathogenesis and potential therapy
OB/GYN & Women's Health Meta-analysis
Narrative review links lactylation modification to gynecological disease pathogenesis and potential therapy New metabolic switch could help treat difficult gynecological conditions
This narrative review addresses the lack of systematic analysis on lactylation modification in gynecological diseases. The authors synthesiz…
A new cellular switch that uses energy to control genes might one day help doctors treat difficult gynecological conditions like endometrios…
Pembrolizumab Plus Paclitaxel Improves Survival in Recurrent Ovarian Carcinoma Compared to Paclitaxel Alone
Oncology RCT
Pembrolizumab Plus Paclitaxel Improves Survival in Recurrent Ovarian Carcinoma Compared to Paclitaxel Alone New Drug Combo Extends Survival for Tough Ovarian Cancer
This randomised, double-blind phase 3 study evaluated pembrolizumab plus paclitaxel versus placebo plus paclitaxel in 643 female participant…
This new combination offers a meaningful survival boost for women with recurrent ovarian cancer that has become resistant to standard treatm…
Systematic review and meta-analysis on LH-active gonadotropins for ovarian stimulation in infertility
Diabetes & Endocrinology Meta-analysis
Systematic review and meta-analysis on LH-active gonadotropins for ovarian stimulation in infertility Adding LH-active hormone to fertility treatment doesn't boost live births
This meta-analysis of 56 RCTs with 14,034 women found little to no difference in live birth or ongoing pregnancy when adding LH-active gonad…
For women using fertility drugs, adding LH doesn't improve live birth or pregnancy odds, but it may slightly lower egg yield without raising…
Network meta-analysis finds GnRHa trigger reduces OHSS risk versus hCG in predicted high responders undergoing IVF
Diabetes & Endocrinology Meta-analysis
Network meta-analysis finds GnRHa trigger reduces OHSS risk versus hCG in predicted high responders undergoing IVF Study compares four IVF trigger methods for women at high risk of over-response
A network meta-analysis of 7 RCTs involving 632 predicted high responders undergoing IVF with GnRH antagonist protocols compared four final …
For women at high risk of painful IVF complications, a specific hormone trigger shot significantly lowers that risk without reducing egg cou…